
Rare cases of COVID returning pose questions for Pfizer pill
Fox News
Pfizer's new OVID-19 pill has now come under scrutiny as a small number of patients relapsed after taking the drug.
But experts say there is still much to be learned about the drug, which was authorized in December for adults at high risk of severe COVID-19 based on a study in which 1,000 adults received the medication.
More Related News













